News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
DIEKMAN JOHN D
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/30/2023 |
4
| DIEKMAN JOHN D (Director) has filed a Form 4 on Zai Lab Ltd
Txns:
| Granted 18,903 shares
@ $26.45, valued at
$500k
|
|
11/15/2022 |
4
| 5AM Partners IV, LLC (10% Owner) has filed a Form 4 on Pear Therapeutics, Inc.
Txns:
| Sold 28,205 shares
@ $3.19, valued at
$90k
Sold 1,175 shares
@ $3.19, valued at
$3.7k
Sold 11,643 shares
@ $2.79, valued at
$32.5k
Sold 485 shares
@ $2.79, valued at
$1.4k
Sold 61,222 shares
@ $2.52, valued at
$154.3k
Sold 2,551 shares
@ $2.52, valued at
$6.4k
|
|
11/02/2022 |
4
| 5AM Partners IV, LLC (10% Owner) has filed a Form 4 on Pear Therapeutics, Inc.
Txns:
| Sold 40,477 shares
@ $2.78, valued at
$112.5k
Sold 1,687 shares
@ $2.78, valued at
$4.7k
Sold 1,408 shares
@ $2.8, valued at
$3.9k
Sold 59 shares
@ $2.8, valued at
$165.2 Sold 10,155 shares
@ $2.72, valued at
$27.6k
Sold 423 shares
@ $2.72, valued at
$1.2k
|
|
10/11/2022 |
4
| 5AM Partners IV, LLC (10% Owner) has filed a Form 4 on scPharmaceuticals Inc.
Txns:
| Sold 30,457 shares
@ $5.02, valued at
$152.9k
Sold 1,269 shares
@ $5.02, valued at
$6.4k
Sold 5,808 shares
@ $5.02, valued at
$29.2k
Sold 456,413 shares
@ $4.09, valued at
$1.9M
Sold 19,017 shares
@ $4.09, valued at
$77.8k
Sold 87,036 shares
@ $4.09, valued at
$356k
|
|
09/16/2022 |
4
| 5AM Partners IV, LLC (10% Owner) has filed a Form 4 on Pear Therapeutics, Inc.
Txns:
| Sold 273,664 shares
@ $1.94, valued at
$530.9k
Sold 11,403 shares
@ $1.94, valued at
$22.1k
Sold 261,840 shares
@ $1.81, valued at
$473.9k
Sold 10,910 shares
@ $1.81, valued at
$19.7k
Sold 337 shares
@ $1.75, valued at
$589.8 Sold 14 shares
@ $1.75, valued at
$24.5 |
|
09/08/2022 |
4
| 5AM Partners IV, LLC (10% Owner) has filed a Form 4 on Pear Therapeutics, Inc.
Txns:
| Sold 298,714 shares
@ $2.36, valued at
$705k
Sold 12,446 shares
@ $2.36, valued at
$29.4k
Sold 148,337 shares
@ $1.92, valued at
$284.8k
Sold 6,181 shares
@ $1.92, valued at
$11.9k
Sold 292,149 shares
@ $1.81, valued at
$528.8k
Sold 12,173 shares
@ $1.81, valued at
$22k
|
|
09/08/2022 |
4
| 5AM Partners IV, LLC (10% Owner) has filed a Form 4 on scPharmaceuticals Inc.
Txns:
| Sold 21,702 shares
@ $5.52, valued at
$119.8k
Sold 904 shares
@ $5.52, valued at
$5k
Sold 4,016 shares
@ $5.52, valued at
$22.2k
Sold 163,034 shares
@ $4.75, valued at
$774.4k
Sold 6,793 shares
@ $4.75, valued at
$32.3k
Sold 30,173 shares
@ $4.75, valued at
$143.3k
|
|
08/18/2022 |
4
| 5AM Partners IV, LLC (10% Owner) has filed a Form 4 on Pear Therapeutics, Inc.
Txns:
| Sold 160,476 shares
@ $1.78, valued at
$285.6k
Sold 6,686 shares
@ $1.78, valued at
$11.9k
Sold 9,674 shares
@ $1.71, valued at
$16.5k
Sold 403 shares
@ $1.71, valued at
$689.1 Sold 213,851 shares
@ $1.55, valued at
$331.5k
Sold 8,910 shares
@ $1.55, valued at
$13.8k
|
|
04/13/2022 |
4
| 5AM Partners IV, LLC (10% Owner) has filed a Form 4 on scPharmaceuticals Inc.
Txns:
| Sold 220,096 shares
@ $5, valued at
$1.1M
Sold 9,171 shares
@ $5, valued at
$45.9k
Sold 40,733 shares
@ $5, valued at
$203.7k
|
|
02/07/2022 |
4
| DIEKMAN JOHN D (Director) has filed a Form 4 on Zai Lab Ltd
Txns:
| Sold 1,000 shares
@ $50.17, valued at
$50.2k
|
|
01/04/2022 |
4
| DIEKMAN JOHN D (Director) has filed a Form 4 on Zai Lab Ltd
Txns:
| Granted 7,763 shares
@ $0 |
|
12/13/2021 |
3
| 5AM Partners IV, LLC (10% Owner) has filed a Form 3 on Pear Therapeutics, Inc. |
11/08/2021 |
4
| DIEKMAN JOHN D (Director) has filed a Form 4 on Zai Lab Ltd
Txns:
| Sold 1,000 shares
@ $91.65, valued at
$91.7k
|
|
08/05/2021 |
4
| DIEKMAN JOHN D (Director) has filed a Form 4 on Zai Lab Ltd
Txns:
| Sold 1,000 shares
@ $149.5, valued at
$149.5k
|
|
05/06/2021 |
4
| DIEKMAN JOHN D (Director) has filed a Form 4 on Zai Lab Ltd
Txns:
| Sold 1,000 shares
@ $153.62, valued at
$153.6k
|
|
01/20/2021 |
4
| DIEKMAN JOHN D (Director) has filed a Form 4 on Zai Lab Ltd
Txns:
| Granted 3,852 shares
@ $0 |
|
01/04/2021 |
3
| DIEKMAN JOHN D (Director) has filed a Form 3 on Zai Lab Ltd |
12/28/2020 |
4
| 5AM Ventures IV, L.P. (10% Owner) has filed a Form 4 on Homology Medicines, Inc.
Txns:
| Sold 480,000 shares
@ $12.82, valued at
$6.2M
Sold 20,000 shares
@ $12.82, valued at
$256.4k
|
|
12/16/2020 |
4
| 5AM Ventures IV, L.P. (10% Owner) has filed a Form 4 on Homology Medicines, Inc.
Txns:
| Sold 151,138 shares
@ $13.0609, valued at
$2M
Sold 328,862 shares
@ $11.88, valued at
$3.9M
Sold 6,297 shares
@ $13.0609, valued at
$82.2k
Sold 13,703 shares
@ $11.88, valued at
$162.8k
|
|
11/13/2020 |
4
| 5AM Ventures IV, L.P. (10% Owner) has filed a Form 4 on IDEAYA Biosciences, Inc.
Txns:
| Sold 657,117 shares
@ $13.66, valued at
$9M
Sold 27,379 shares
@ $13.66, valued at
$374k
Sold 115,504 shares
@ $13.66, valued at
$1.6M
|
|
10/07/2020 |
4
| 5AM Ventures IV, L.P. (Former 10% holder) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns:
| Sold 175,000 shares
@ $25.3, valued at
$4.4M
|
|
06/18/2020 |
4
| 5AM Ventures IV, L.P. (10% Owner) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns:
| Sold 115,357 shares
@ $33.3, valued at
$3.8M
Sold 4,807 shares
@ $33.3, valued at
$160.1k
Sold 19,836 shares
@ $33.3, valued at
$660.5k
|
|
06/15/2020 |
4
| 5AM Ventures IV, L.P. (10% Owner) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns:
| Sold 235,200 shares
@ $28.7527, valued at
$6.8M
Sold 9,800 shares
@ $28.7527, valued at
$281.8k
|
|
05/21/2020 |
4
| 5AM Ventures IV, L.P. (10% Owner) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns:
| Sold 244,800 shares
@ $35.15, valued at
$8.6M
Sold 10,200 shares
@ $35.15, valued at
$358.5k
|
|
12/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/09/2019 |
4
| 5AM Ventures IV, L.P. (10% Owner) has filed a Form 4 on Aprea Therapeutics, Inc.
Txns:
| Converted 1,913,910 shares
@ $0 Converted 79,746 shares
@ $0 Converted 492,475 shares
@ $0 Converted 20,519 shares
@ $0 Bought 333,333 shares
@ $15, valued at
$5M
Converted 1,913,910 convertible preferred
@ $0 Converted 79,746 convertible preferred
@ $0 Converted 492,475 convertible preferred
@ $0 Converted 20,519 convertible preferred
@ $0 |
|
10/02/2019 |
3
| 5AM Ventures IV, L.P. (10% Owner) has filed a Form 3 on Aprea Therapeutics, Inc. |
09/18/2019 |
4
| 5AM VENTURES III, L.P. (10% Owner) has filed a Form 4 on ARVINAS, INC.
Txns:
| Disposed of 438,694 shares
@ $0 Disposed of 11,306 shares
@ $0 Acquired 85,396 shares
@ $0 Acquired 17,079 shares
@ $0 Acquired 17,079 shares
@ $0 Acquired 8,540 shares
@ $0 Acquired 8,540 shares
@ $0 Acquired 1,002 shares
@ $0 |
|
07/01/2019 |
4
| 5AM VENTURES III, L.P. (10% Owner) has filed a Form 4 on ARVINAS, INC.
Txns:
| Sold 438,694 shares
@ $21.75, valued at
$9.5M
Sold 11,306 shares
@ $21.75, valued at
$245.9k
Sold 350,955 shares
@ $22.02, valued at
$7.7M
Sold 9,045 shares
@ $22.02, valued at
$199.2k
|
|
06/25/2019 |
4
| 5AM Ventures IV, L.P. (Former 10% holder) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns:
| Sold 240,000 shares
@ $22.2, valued at
$5.3M
Sold 10,000 shares
@ $22.2, valued at
$222k
|
|
06/11/2019 |
4
| 5AM VENTURES III, L.P. (10% Owner) has filed a Form 4 on ARVINAS, INC.
Txns:
| Sold 185,226 shares
@ $19.65, valued at
$3.6M
Sold 4,774 shares
@ $19.65, valued at
$93.8k
|
|
05/28/2019 |
4
| DIEKMAN JOHN D (Director) has filed a Form 4 on IDEAYA Biosciences, Inc.
Txns:
| Converted 1,721,898 shares
@ $0 Converted 578,447 shares
@ $0 Converted 71,745 shares
@ $0 Converted 24,101 shares
@ $0 Bought 240,000 shares
@ $10, valued at
$2.4M
Bought 10,000 shares
@ $10, valued at
$100k
Converted 1,721,898 preferred shares
@ $0 Converted 578,447 preferred shares
@ $0 Converted 71,745 preferred shares
@ $0 Converted 24,101 preferred shares
@ $0 |
|
05/22/2019 |
3
| DIEKMAN JOHN D (Director) has filed a Form 3 on IDEAYA Biosciences, Inc. |
05/20/2019 |
4
| 5AM Ventures IV, L.P. (10% Owner) has filed a Form 4 on Homology Medicines, Inc.
Txns:
| Sold 590,400 shares
@ $21.47, valued at
$12.7M
Sold 24,600 shares
@ $21.47, valued at
$528.2k
|
|
|
|
|